D. D. Holsworth

发表

Recent Advances in Wnt/β-Catenin Pathway Small-Molecule Inhibitors

S. Krauss, D. Holsworth, D. D. Holsworth, 2012 .

Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor.

G. Drewes, H. Dinh, S. Krauss, 2013, Journal of medicinal chemistry.

Metabolic Aromatization of N-Alkyl-1,2,3,4-Tetrahydroquinoline Substructures to Quinolinium by Human Liver Microsomes and Horseradish Peroxidase

G. S. Walker, R. Voorman, D. Holsworth, 2006, Drug Metabolism and Disposition.

A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.

S. Krauss, M. Merchant, P. Polakis, 2013, Cancer research.

Structure-based Design of Selective and Potent Inhibitors of Protein-tyrosine Phosphatase β*

M. J. Newman, O. Olsen, L. Iversen, 2004, Journal of Biological Chemistry.

A Novel Synthetic Smoothened Antagonist Transiently Inhibits Pancreatic Adenocarcinoma Xenografts in a Mouse Model

S. Krauss, D. Petersen, I. Okun, 2011, PloS one.

Binding thermodynamics of substituted diaminopyrimidine renin inhibitors.

N. Powell, Michael D. Kaufman, S. D. Emerson, 2007, Analytical biochemistry.

Augmentation of aortic ring contractions by angiotensin II antisense peptide.

R. Root-Bernstein, P. Dillon, D. Holsworth, 1998, Hypertension.

Use of electrospray ionization mass spectrometry to probe antisense peptide interactions.

J. Loo, R. Root-Bernstein, D. Holsworth, 1994, Biological mass spectrometry.

Biochemical characterization of a novel high‐affinity and specific plasma kallikrein inhibitor

D. Kolte, Z. Shariat-Madar, D. Holsworth, 2011, British journal of pharmacology.